Medical-grade alert diagnostics from cloth

Nanowear is the new standard-bearer for remote monitoring utilizing it's proprietary cloth-based nanotechnology. These nanosensors capture 15+ medical grade bio markers directly from the skin, enabling a closed loop digital system for specific machine-learning algorithms built on terabytes of unique human data.

While the first targeted therapeutic vertical is cardiovascular/congestive Heart Failure alert diagnostics, Nanowear’s connected-care platform has multiple application opportunities across therapeutics and other industry verticals, including neurological monitoring, clinical and pharmaceutical research, and military and industrial safety

Value-based outcomes with unparalleled patient experience and quality of life

Millions of individuals suffer from chronic diseases that require continuous monitoring, many of whom are Medicaid, Medicare or uninsured patients. This population is the single largest driver of healthcare costs worldwide.

Heart Failure, the chronic disease management case of our time, affects 7 million Americans costing the US healthcare system $40 billion annually due to all-too frequent Heart Failure related hospitalizations. One-third of these patients are Medicaid or uninsured.

Beginning with Heart Failure and related co-morbidities, Nanowear delivers high-fidelity alert diagnostics and bridges the gap between cost reduction and patient care. Nanowear's goal is to protect patient lives and enable the flexibility to live freely.

Awards and Recognition

Nanowear receives Frost & Sullivan 2018 Visionary Innovation Leader Award

“Frost & Sullivan research shows that Nanowear’s innovative textile captures and transmits millions of skin-based signals to unlock advanced biometric insights in real time. The result offers providers a rich data stream with which to manage complex disease states; at the same, patients receive a comfortable and discreet means of tracking their health. An additional and unique selling point is Nanowear’s full-stack software development and analytics / alert algorithm that exceeds industry norms to provide advanced sensor modalities and raw data analysis ... Overall, Nanowear is a shining star in the medtech start-up arena.”

— Frost & Sullivan: Visionary Innovation Leader Award for Remote Diagnostic Monitoring

Nanowear CEO named to the AdvaMed Board of Directors

The Advanced Medical Technology Association (AdvaMed), is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. AdvaMed’s membership has reached over 400 members and more than 80 employees with a global presence in countries including Europe, India, China, Brazil, and Japan.

Nanowear crowned 2018 SXSW Pitch Health & Wearables and Best-in-Show Champion

Nanowear named Innovation Champion of the Accenture HealthTech Innovation Challenge

Nanowear received the award for its congestive heart failure (CHF) monitoring device called SimpleSense. It is a non-invasive undergarment solution worn by patients of a CHF-related hospitalization event which captures and transmits CHF data to a cloud-based environment, providing access and updates to medical professionals for assessment of patient health and progress. The award was presented Jan. 8 at the StartUp Health Festival during the 36th annual J.P. Morgan Healthcare Conference in San Francisco.

Nanowear awarded Grand Prize of the 2017 Philips Wearables Challenge

Launched in summer of 2017, the Philips Wearables Challenge called for novel solutions to predict early signs of patient deterioration and prevent hospital readmission. Forty teams from across the country submitted their cutting edge technologies and systems to facilitate early, appropriate interventions.

Nanowear wins 2017 Execution Award at the MedTech Conference

“Nanowear represents what is so great about the medical technology industry: a strong entrepreneurial spirit combined with next-generation innovation with the goal of improving patient care. With receipt of this award, Nanowear is one step closer to bringing their technology to patients and their physicians, and we are excited to have helped move this process forward.”

— Ashley Wittorf, executive director, AdvaMed Accel

Nanowear one of seven medtech companies selected for Google Launchpad Studio

Based in San Francisco, Launchpad Studio is a fully tailored product development acceleration program that matches top ML startups and experts from Silicon Valley with the best of Google - its people, network, and advanced technologies - to help accelerate applied ML and AI innovation. The program's mandate is to support the growth of the ML ecosystem, and to develop product methodologies for ML.

Cloth-based nanotechnology revolutionizing